Abbott Laboratories Q3 Earnings Report Shows $1.15 Earnings Per Share
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowAbbott Laboratories reported earnings per share (EPS) of $1.15 for the third quarter, exceeding analysts' expectations. Revenue for the quarter reached $10.2 billion, reflecting a year-over-year increase of 5%. The company has a price-to-earnings (P/E) ratio of 22.4. This performance may influence market sentiment regarding healthcare stocks, particularly in the context of ongoing economic recovery.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Abbott Laboratories (ABT)
Abbott Laboratories is a diversified healthcare company spanning diagnostics, medical devices, and nutrition.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
ABT stock page and all news →Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
